Samsara BioCapital, LLC
Annual return '25
+13.5%
SPY '25
+17.7%
Alpha
-4.2ptsvs SPY
Invested
$1B
Holdings
22
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 99%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$SRRK
SCHOLAR ROCK HLDG CORP
Q4 2024: New position (5.61M shares)
32.9%
02
$MLYS
MINERALYS THERAPEUTICS INC
Q3 2025: Increased +10.4% (5.67M → 6.26M shares)
15.5%
03
$ALMS
ALUMIS INC
Q2 2025: Increased +47.0% (3.27M → 4.80M shares)
13.6%
04
$SEPN
SEPTERNA INC
Q1 2025: Increased +13.8% (2.77M → 3.15M shares)
7.4%
05
$KLRS
KALARIS THERAPEUTICS INC
Q1 2025: New position (11.45M shares)
7.3%
06
$SGP
SPYGLASS PHARMA INC
Held since at least Q1 2024
5.3%
07
$NGNE
NEUROGENE INC
Q4 2024: New position (1.72M shares)
3.4%
08
$IVA
INVENTIVA SA
Held since at least Q1 2024
2.8%
09
$STRO
SUTRO BIOPHARMA INC
Held since at least Q1 2024
2.6%
10
$JBIO
JADE BIOSCIENCES INC
Q2 2025: New position (531.2k shares)
1.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:31 UTC.